Bristol Myers Squibb finally breaks into first-line lung cancer with Opdivo-Yervoy nod chelfand Fri, 05/15/2020 – 16:11
The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with […]
Bristol Myers snags Pomalyst green light in rare AIDS-related skin lesions chelfand Fri, 05/15/2020 – 11:46
Blueprint’s Ayvakit gets FDA no-go in new stomach cancer use but presses ahead in blood disorder aliu Fri, […]
Univercells inks deal to produce prefabricated vaccine facilities for potential COVID-19 shot kblankenship Fri, 05/15/2020 – 10:53
FiercePharmaAsia—Gilead’s remdesivir licensing; Legend’s $100M IPO; Takeda’s blockbuster hopefuls aliu Fri, 05/15/2020 – 07:57
A research team has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein […]
Staff should not need to fight for adequate protection at work, but the legal challenge launched against NHS […]
There has been a surge in cases of an inflammatory syndrome in children, believed to be linked to […]